Results 251 to 260 of about 1,109,815 (338)
Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment. [PDF]
Sun X+7 more
europepmc +1 more source
Injectable pH responsive conductive hydrogel for intelligent delivery of metformin and exosomes to alleviate myocardial ischemia‐reperfusion injury. The hydrogel responds to the weakly acidic microenvironment of ischemic injury and can significantly reduce the production of intracellular ROS and enhance cardiac conduction, thereby resisting apoptosis ...
Nianlan Cheng+11 more
wiley +1 more source
How AI drives innovation in cardiovascular medicine. [PDF]
Cerrato PL, Halamka JD.
europepmc +1 more source
Endomyocardial fibrosis and calcification in an elderly patient
Tomonobu Yanase+3 more
doaj +1 more source
HNF3α Targets Nckap1l and Promotes Renal Fibrosis Following Ischemia‐Reperfusion Injury
Hepatocyte Nuclear Factor 3 alpha (HNF3α) is significantly upregulated in renal tubular epithelial cells of CKD patients and fibrotic mice. Deletion of HNF3α mitigates IRI‐induced renal fibrosis, while overexpression worsens it. HNF3α directly regulates NCK‐associated protein 1‐like (Nckap1l), whose overexpression exacerbates fibrosis.
Ling Hou+7 more
wiley +1 more source
Quantitative Angiography: The Dawn of a New Era in Cardiovascular Medicine. [PDF]
Sawant R+3 more
europepmc +1 more source
This review explores the challenges of treating bone and cartilage defects, emphasizing the role of endogenous electric fields in bone and cartilage regeneration. It highlights recent advancements in electroactive biomaterials, including nanogenerators, piezoelectric materials, triboelectric scaffold, and zwitterionic hydrogels.
Yubin Yao+4 more
wiley +1 more source